Cue Biopharma Stock Price History

CUE Stock

USD 0.88 0.02 1.89%

Below is the normalized historical share price chart for Cue Biopharma extending back to January 02, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cue Biopharma stands at 0.88, as last reported on the 21st of July, with the highest price reaching 0.98 and the lowest price hitting 0.82 during the day.

IPO Date

2nd of January 2018

200 Day MA

1.0459

50 Day MA

0.7018

Beta

1.423

Covid

If you're considering investing in Cue Stock, it is important to understand the factors that can impact its price. Cue Biopharma appears to be dangerous, given 3 months investment horizon. Cue Biopharma secures Sharpe Ratio (or Efficiency) of 0.0611, which signifies that the company had a 0.0611 % return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Cue Biopharma, which you can use to evaluate the volatility of the firm. Please makes use of Cue Biopharma's mean deviation of 3.93, and Risk Adjusted Performance of 0.0657 to double-check if our risk estimates are consistent with your expectations.

Build AI portfolio with Cue Stock

At present, Cue Biopharma's Stock Based Compensation is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 22.2 M, whereas Common Stock Total Equity is forecasted to decline to about 26.3 K. . As of July 21, 2025, Price To Sales Ratio is expected to decline to 6.28. In addition to that, Price Earnings Ratio is expected to decline to -1.58. Cue Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0611

Best Portfolio	Best Equity
Good Returns
Average Returns
Small Returns			CUE
Cash	Small Risk	Average Risk	High Risk	Huge Risk
Negative Returns

Estimated Market Risk

5.92

actual daily

53% of assets are less volatile

Expected Return

0.36

actual daily

93% of assets have higher returns

Risk-Adjusted Return

0.06

actual daily

96% of assets perform better

Based on monthly moving average Cue Biopharma is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cue Biopharma by adding it to a well-diversified portfolio.

Price Book

10.3062

Enterprise Value Ebitda

(1.76)

Price Sales

8.4864

Shares Float

75.1 M

Wall Street Target Price

Cue Biopharma Stock Price History Chart

There are several ways to analyze Cue Stock price data. The simplest method is using a basic Cue candlestick price chart, which shows Cue Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Highest Price	July 18, 2025	0.9
Lowest Price	June 17, 2025	0.58

Cue Biopharma July 21, 2025 Stock Price Synopsis

Various analyses of Cue Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cue Stock. It can be used to describe the percentage change in the price of Cue Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cue Stock.

	Cue Biopharma Price Rate Of Daily Change	0.98
	Cue Biopharma Price Daily Balance Of Power	(0.11)
	Cue Biopharma Price Action Indicator	(0.03)

Cue Biopharma July 21, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Cue Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Cue Biopharma intraday prices and daily technical indicators to check the level of noise trading in Cue Stock and then apply it to test your longer-term investment strategies against Cue.

Cue Stock Price History Data

The price series of Cue Biopharma for the period between Tue, Apr 22, 2025 and Mon, Jul 21, 2025 has a statistical range of 0.32 with a coefficient of variation of 10.28. The prices are distributed with arithmetic mean of 0.72. The median price for the last 90 days is 0.73.

	Open	High	Low	Close	Volume
07/21/2025	0.90	0.98	0.82	0.88
07/21/2025	0.90	0.98	0.82	0.88
07/18/2025	0.83	0.98	0.82	0.90	494,445
07/17/2025	0.85	0.88	0.81	0.84	584,645
07/16/2025	0.70	1.03	0.70	0.86	6,299,569
07/15/2025	0.76	0.79	0.70	0.70	178,870
07/14/2025	0.76	0.80	0.72	0.78	110,293
07/11/2025	0.78	0.80	0.71	0.77	220,953
07/10/2025	0.79	0.83	0.75	0.80	116,407
07/09/2025	0.74	0.80	0.74	0.78	198,978
07/08/2025	0.71	0.75	0.68	0.73	260,001
07/07/2025	0.69	0.71	0.67	0.70	72,337
07/03/2025	0.69	0.71	0.67	0.70	66,632
07/02/2025	0.68	0.71	0.65	0.69	225,500
07/01/2025	0.68	0.70	0.65	0.67	822,000
06/30/2025	0.74	0.76	0.68	0.68	152,500
06/27/2025	0.79	0.79	0.74	0.74	233,700
06/26/2025	0.77	0.79	0.73	0.79	106,697
06/25/2025	0.74	0.88	0.72	0.79	777,587
06/24/2025	0.66	0.73	0.65	0.72	1,005,190
06/23/2025	0.67	0.70	0.65	0.66	132,338
06/20/2025	0.69	0.74	0.62	0.70	1,080,713
06/18/2025	0.58	0.67	0.54	0.66	468,878
06/17/2025	0.59	0.62	0.56	0.58	128,032
06/16/2025	0.60	0.63	0.57	0.59	123,682
06/13/2025	0.64	0.66	0.59	0.60	97,092
06/12/2025	0.62	0.66	0.62	0.64	176,095
06/11/2025	0.63	0.66	0.62	0.64	118,449
06/10/2025	0.62	0.67	0.62	0.63	122,256
06/09/2025	0.65	0.66	0.61	0.64	121,799
06/06/2025	0.62	0.66	0.62	0.64	132,233
06/05/2025	0.63	0.67	0.61	0.63	181,285
06/04/2025	0.62	0.65	0.61	0.62	145,721
06/03/2025	0.64	0.67	0.63	0.63	111,304
06/02/2025	0.63	0.66	0.60	0.65	143,055
05/30/2025	0.64	0.67	0.63	0.64	114,180
05/29/2025	0.64	0.67	0.63	0.64	99,775
05/28/2025	0.69	0.69	0.61	0.63	112,307
05/27/2025	0.65	0.70	0.64	0.66	142,003
05/23/2025	0.69	0.70	0.65	0.66	307,027
05/22/2025	0.61	0.71	0.61	0.71	478,946
05/21/2025	0.67	0.67	0.60	0.60	348,818
05/20/2025	0.72	0.72	0.66	0.67	159,763
05/19/2025	0.72	0.74	0.69	0.71	142,684
05/16/2025	0.73	0.75	0.72	0.72	120,374
05/15/2025	0.74	0.75	0.70	0.72	85,098
05/14/2025	0.77	0.77	0.74	0.75	106,594
05/13/2025	0.73	0.77	0.68	0.77	274,326
05/12/2025	0.77	0.78	0.75	0.75	159,546
05/09/2025	0.77	0.78	0.75	0.78	94,813
05/08/2025	0.78	0.78	0.76	0.77	58,264
05/07/2025	0.77	0.78	0.74	0.77	135,553
05/06/2025	0.77	0.77	0.71	0.75	176,368
05/05/2025	0.76	0.79	0.75	0.78	86,441
05/02/2025	0.76	0.80	0.74	0.75	71,095
05/01/2025	0.75	0.79	0.74	0.75	48,893
04/30/2025	0.76	0.79	0.73	0.76	133,133
04/29/2025	0.79	0.86	0.76	0.76	89,115
04/28/2025	0.80	0.81	0.78	0.79	16,217
04/25/2025	0.86	0.86	0.78	0.79	136,332
04/24/2025	0.85	0.86	0.80	0.86	143,740

About Cue Biopharma Stock history

Cue Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cue is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cue Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cue Biopharma stock prices may prove useful in developing a viable investing in Cue Biopharma

	Last Reported	Projected for Next Year
Common Stock Shares Outstanding	56.3 M	31.7 M
Net Loss	-47.7 M	-50.1 M

Cue Biopharma Quarterly Net Working Capital

433,000

Cue Biopharma Stock Technical Analysis

Cue Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.

Volatility Indicators

View

Value Movement

View

A focus of Cue Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cue Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Manager Now

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital

All Next

Launch Module

Cue Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Cue Biopharma's price direction in advance. Along with the technical and fundamental analysis of Cue Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cue to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

	Risk Adjusted Performance	0.0657
	Jensen Alpha	0.2338
	Total Risk Alpha	(0.47)
	Sortino Ratio	0.042
	Treynor Ratio	0.4026

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

Complementary Tools for Cue Stock analysis

When running Cue Biopharma's price analysis, check to measure Cue Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cue Biopharma is operating at the current time. Most of Cue Biopharma's value examination focuses on studying past and present price action to predict the probability of Cue Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cue Biopharma's price. Additionally, you may evaluate how the addition of Cue Biopharma to your portfolios can decrease your overall portfolio volatility.

	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Global Correlations Find global opportunities by holding instruments from different markets
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Transaction History View history of all your transactions and understand their impact on performance
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Stocks Directory Find actively traded stocks across global markets

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Cue Biopharma Stock Price History

Sharpe Ratio = 0.0611

Estimated Market Risk

Expected Return

Risk-Adjusted Return

Cue Biopharma Stock Price History Chart

Cue Biopharma July 21, 2025 Stock Price Synopsis

Cue Biopharma July 21, 2025 Stock Price Analysis

Cue Stock Price History Data

About Cue Biopharma Stock history

Cue Biopharma Quarterly Net Working Capital

433,000

Cue Biopharma Stock Technical Analysis

Did you try this?

Run Portfolio Manager Now

Portfolio Manager

Cue Biopharma Technical and Predictive Indicators

Complementary Tools for Cue Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY